| 221 |
Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute |
Department of Radiotherapy and Nuclear medicine |
2021 |
| 222 |
Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute |
Department of Radiotherapy and Nuclear medicine |
2021 |
| 223 |
Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute |
Department of Pediatric Oncology |
2021 |
| 224 |
Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute |
Department of Pediatric Oncology |
2021 |
| 225 |
Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute |
Department of Pediatric Oncology |
2021 |
| 226 |
Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute |
Department of Pediatric Oncology |
2021 |
| 227 |
Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute |
Department of Pediatric Oncology |
2021 |
| 228 |
Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute |
Department of Pediatric Oncology |
2021 |
| 229 |
Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute |
Department of Pediatric Oncology |
2021 |
| 230 |
Micro-RNA 155 in non-Hodgkin lymphoma |
Department of Clinical Pathology |
2021 |
